Why this matters to buyers
Buyers in the pharmaceutical supply chain, including those sourcing active pharmaceutical ingredients (APIs) or finished generic drugs, may face significant cost increases and supply chain disruptions if these tariffs are implemented. The highly globalized nature of the supply chain suggests potential widespread impact.
Recommended buyer actions
- Review and map the full supply chain for generic pharmaceuticals and APIs to identify exposure to potential tariffs.
- Assess inventory levels and consider strategic stockpiling or alternative sourcing options.
- Engage with logistics providers to understand potential impacts on shipping routes and costs.
Original source context
The Trump administration aims to impose major tariffs on generic medicines, targeting one of the world’s most complex supply chains. The post Trump’s tariff on drugs targets one of the world’s most globalized supply chains appeared first on FreightWaves.
Read the original report · FreightWaves